文献速递前列腺癌前列腺增生与排尿功能障碍

倾向性评分匹配评估姑息性经尿道前列腺电切术与钬激光前列腺剜除术治疗前列腺癌患者膀胱出口梗阻

Propensity score-matched evaluation of palliative transurethral resection and holmium laser enucleation of the prostate for bladder outlet obstruction in patients with prostate cancer.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2024-04-10

本研究为回顾性倾向性评分匹配分析,比较2014至2021年间因下尿路症状/膀胱出口梗阻接受经尿道前列腺电切术(TURP,1373例)或钬激光前列腺剜除术(HoLEP,2705例)的患者,按年龄、前列腺体积和术前国际前列腺症状评分(IPSS)匹配。结果显示两种技术术后症状和尿动力学参数均改善,但姑息性适应症患者切除和剜除时间显著增加,无前列腺癌患者手术效率(g/min)高两倍,姑息性患者血红蛋白下降高两倍,不良事件相当。结论认为两种技术均提供充分症状改善和可比安全性,但前列腺癌患者手术难度增加。

要点

  • 姑息性适应症患者TURP和HoLEP的切除和剜除时间显著增加。
  • 无前列腺癌患者两种技术的手术效率(g/min)高两倍。
  • 姑息性患者血红蛋白下降高两倍,不良事件两组相当。

核心结论

  • 目前局部晚期前列腺癌伴膀胱出口梗阻患者尚无标准治疗;数据显示TURP和HoLEP均提供充分症状改善和可比安全性,但前列腺癌患者两种手术均变得更困难。

研究设计与样本

  • 回顾性倾向性评分匹配分析,纳入2014至2021年间因下尿路症状/膀胱出口梗阻接受TURP(1373例)或HoLEP(2705例)的男性,按年龄、前列腺体积和术前国际前列腺症状评分(IPSS)匹配。

主要发现

  • 无论技术如何,术后症状和尿动力学参数均改善。
  • 姑息性适应症患者切除和剜除时间显著增加。
  • 无前列腺癌患者两种技术的手术效率(g/min)高两倍。
  • 姑息性患者血红蛋白下降高两倍,不良事件两组相当。

临床怎么用

  • 作者认为TURP和HoLEP均可为膀胱出口梗阻患者提供充分症状改善和可比安全性,但前列腺癌患者手术难度增加。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While transurethral resection of the prostate (TURP) is the standard-of-care, Holmium laser enucleation of the prostate (HoLEP) is widely accepted as a size-independent method for surgical treatment of patients with lower urinary tract symptoms (LUTS) secondary to bladder outlet obstruction (BOO). However, in an ageing society an increasing number of patients presents with BOO due to locally advanced prostate cancer. There is currently no guidelines recommendation as to the enucleation or resection technique. Therefore, we compared intraoperative performance, postoperative outcomes, and safety for palliative (p)TURP and (p)HoLEP. METHODS: We conducted a retrospective, propensity score-matched analysis of 1373 and 2705 men who underwent TURP or HoLEP for LUTS/BOO between 2014 and 2021, respectively. Patients were matched for age, prostate size and preoperative international prostate symptom score (IPSS). Patients were stratified by technique and groups were compared for perioperative parameters, safety, and functional outcomes. RESULTS: While postoperative symptoms and urodynamic parameters improved irrespective of technique, we report significantly increased resection and enucleation times for palliative indication. For corresponding efficiency parameters, we observed a two-fold higher surgical performance (g/min) for both techniques in patients without prostate cancer. While adverse events were comparable between groups, we found a two-fold higher hemoglobin drop in palliative patients. CONCLUSIONS: Currently, there is no standard-of-care for patients with BOO and locally advanced prostate cancer. Our data show that both TURP and HoLEP offer adequate symptom improvement and comparable safety profiles. While HoLEP is feasible even in larger prostates, both procedures become more difficult in patients with prostate cancer. Taken together, this study covers an important gap in current literature, helping urological surgeons to make evidence-based decisions for the benefit of their patients.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Tamalunas A, Keller P, Schott M, et al. Propensity score-matched evaluation of palliative transurethral resection and holmium laser enucleation of the prostate for bladder outlet obstruction in patients with prostate cancer. Prostate Cancer Prostatic Dis. 2024. PMID: 38600321. doi:10.1038/s41391-024-00831-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。